BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Diluted earnings per share

Latest
1.20
↑ 264% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
-0.73
Historical baseline
PeriodValueYoY Change
TTM1.20+378.8%
2024-0.43+63.6%
2023-1.18+11.3%
2022-1.33-29.1%
2021-1.03+5.5%
2020-1.09-16.0%
2019-0.94+4.1%
2018-0.98-25.6%
2017-0.78-4.0%
2016-0.75-